Who Paid My Doc
Denton Watumull
Plastic and Reconstructive Surgery Richardson, TX Medical Doctor
NPI 1225073216 CMS profile 237084
3201 George Bush Hwy, #101, Richardson, TX 75082
General payments
$5,623
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$3,700
Through program year 2025, Denton Watumull of Richardson, TX is reported in the CMS Open Payments database as having received $5,623 across 88 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $3,700 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 72nd percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $420 | 13 | |
| 2024 | General | $377 | 10 | |
| 2023 | General | $355 | 8 | |
| 2022 | General | $673 | 13 | |
| 2021 | General | $737 | 16 | |
| 2020 | General | $267 | 9 | |
| 2019 | General | $2,794 | 19 |
Beside peers
- Denton Watumull
- Plastic and Reconstructive Surgery median
- Middle half of Plastic and Reconstructive Surgery
- National median
In program year 2025, general payments to Denton Watumull were reported at $420. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.
Show as a table
| Year | Denton Watumull | Plastic and Reconstructive Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $2,794 | $335 | $121–$1,264 | $163 |
| 2020 | $267 | $162 | $57–$417 | $114 |
| 2021 | $737 | $245 | $89–$735 | $132 |
| 2022 | $673 | $325 | $120–$932 | $149 |
| 2023 | $355 | $343 | $129–$999 | $160 |
| 2024 | $377 | $390 | $141–$1,085 | $164 |
| 2025 | $420 | $442 | $150–$1,242 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
88 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Plastic and Reconstructive Surgery in Texas
Aldona Spiegel
Plastic and Reconstructive Surgery · Houston, TX
Charles Butler
Plastic and Reconstructive Surgery · Houston, TX
Michael Klebuc
Plastic and Reconstructive Surgery · Houston, TX
Joshua Lemmon
Plastic and Reconstructive Surgery · Richardson, TX
Patrick Garvey
Plastic and Reconstructive Surgery · Houston, TX
Rukmini Rednam
Plastic and Reconstructive Surgery · Houston, TX
Related records
Plastic and Reconstructive Surgery in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Plastic and Reconstructive Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.